NHS reimbursement of new cancer drugs: Is NICE getting nastier?

A. R. Mason, M. F. Drummond

Centre for Health Economics

Research output: Contribution to journal › Meeting abstract › peer-review

Abstract

(abstract from the ISPOR thirteenth annual international meeting May 3-7 2008)

Original language	English
Pages (from-to)	A11-A11
Number of pages	1
Journal	Value in Health
Volume	11
Issue number	3
Publication status	Published - 2008

Cite this

@article{328f3f809689499591bd3b49ed246fdc,

title = "NHS reimbursement of new cancer drugs: Is NICE getting nastier?",

abstract = "(abstract from the ISPOR thirteenth annual international meeting May 3-7 2008)",

author = "Mason, {A. R.} and Drummond, {M. F.}",

year = "2008",

language = "English",

volume = "11",

pages = "A11--A11",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - NHS reimbursement of new cancer drugs: Is NICE getting nastier?

AU - Mason, A. R.

AU - Drummond, M. F.

PY - 2008

Y1 - 2008

N2 - (abstract from the ISPOR thirteenth annual international meeting May 3-7 2008)

AB - (abstract from the ISPOR thirteenth annual international meeting May 3-7 2008)

M3 - Meeting abstract

SN - 1098-3015

VL - 11

SP - A11-A11

JO - Value in Health

JF - Value in Health

IS - 3

ER -